Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 2
1956 1
1961 1
1964 3
1966 1
1969 4
1972 1
1973 4
1974 1
1977 3
1978 6
1979 9
1980 6
1981 11
1982 7
1983 4
1984 5
1985 3
1986 4
1987 6
1988 3
1989 4
1991 3
1992 2
1993 3
1994 1
1995 4
1996 7
1997 6
1998 4
1999 6
2000 5
2001 8
2002 3
2003 8
2004 7
2005 14
2006 6
2007 13
2008 9
2009 11
2010 16
2011 13
2012 11
2013 5
2014 3
2015 2
2016 8
2017 11
2018 7
2019 9
2020 14
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

301 results
Results by year
Filters applied: . Clear all
Page 1
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.
Pascual J, Berger SP, Witzke O, Tedesco H, Mulgaonkar S, Qazi Y, Chadban S, Oppenheimer F, Sommerer C, Oberbauer R, Watarai Y, Legendre C, Citterio F, Henry M, Srinivas TR, Luo WL, Marti A, Bernhardt P, Vincenti F; TRANSFORM Investigators. Pascual J, et al. Among authors: vincenti f. J Am Soc Nephrol. 2018 Jul;29(7):1979-1991. doi: 10.1681/ASN.2018010009. Epub 2018 May 11. J Am Soc Nephrol. 2018. PMID: 29752413 Free PMC article. Clinical Trial.
Belatacept and Long-Term Outcomes in Kidney Transplantation.
Vincenti F, Rostaing L, Grinyo J, Rice K, Steinberg S, Gaite L, Moal MC, Mondragon-Ramirez GA, Kothari J, Polinsky MS, Meier-Kriesche HU, Munier S, Larsen CP. Vincenti F, et al. N Engl J Med. 2016 Jan 28;374(4):333-43. doi: 10.1056/NEJMoa1506027. N Engl J Med. 2016. PMID: 26816011 Free article. Clinical Trial.
Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study.
Berger SP, Sommerer C, Witzke O, Tedesco H, Chadban S, Mulgaonkar S, Qazi Y, de Fijter JW, Oppenheimer F, Cruzado JM, Watarai Y, Massari P, Legendre C, Citterio F, Henry M, Srinivas TR, Vincenti F, Gutierrez MPH, Marti AM, Bernhardt P, Pascual J; TRANSFORM investigators. Berger SP, et al. Among authors: vincenti f. Am J Transplant. 2019 Nov;19(11):3018-3034. doi: 10.1111/ajt.15480. Epub 2019 Jul 1. Am J Transplant. 2019. PMID: 31152476 Free article. Clinical Trial.
A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).
Vincenti F, Charpentier B, Vanrenterghem Y, Rostaing L, Bresnahan B, Darji P, Massari P, Mondragon-Ramirez GA, Agarwal M, Di Russo G, Lin CS, Garg P, Larsen CP. Vincenti F, et al. Am J Transplant. 2010 Mar;10(3):535-46. doi: 10.1111/j.1600-6143.2009.03005.x. Am J Transplant. 2010. PMID: 20415897 Free article. Clinical Trial.
Belatacept.
Vincenti F, Dritselis A, Kirkpatrick P. Vincenti F, et al. Nat Rev Drug Discov. 2011 Aug 31;10(9):655-6. doi: 10.1038/nrd3536. Nat Rev Drug Discov. 2011. PMID: 21878974 No abstract available.
KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary.
Kasiske BL, Zeier MG, Chapman JR, Craig JC, Ekberg H, Garvey CA, Green MD, Jha V, Josephson MA, Kiberd BA, Kreis HA, McDonald RA, Newmann JM, Obrador GT, Vincenti FG, Cheung M, Earley A, Raman G, Abariga S, Wagner M, Balk EM; Kidney Disease: Improving Global Outcomes. Kasiske BL, et al. Among authors: vincenti fg. Kidney Int. 2010 Feb;77(4):299-311. doi: 10.1038/ki.2009.377. Epub 2009 Oct 21. Kidney Int. 2010. PMID: 19847156 Free article.
Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants.
Chandran S, Tang Q, Sarwal M, Laszik ZG, Putnam AL, Lee K, Leung J, Nguyen V, Sigdel T, Tavares EC, Yang JYC, Hellerstein M, Fitch M, Bluestone JA, Vincenti F. Chandran S, et al. Among authors: vincenti f. Am J Transplant. 2017 Nov;17(11):2945-2954. doi: 10.1111/ajt.14415. Epub 2017 Aug 14. Am J Transplant. 2017. PMID: 28675676 Free PMC article. Clinical Trial.
301 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page